Terms: = Head and neck cancer AND RUNX1T1, ENSG00000079102, 862 AND Prognosis
27 results:
1. Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer.
Lu D; Wu X; Wu W; Wu S; Li H; Zhang Y; Yan X; Zhai J; Dong X; Feng S; Zhang X; Sun F; Wang S; Cai K
Cell Death Dis; 2023 Dec; 14(12):843. PubMed ID: 38114477
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis.
Mehanna H; Taberna M; von Buchwald C; Tous S; Brooks J; Mena M; Morey F; Grønhøj C; Rasmussen JH; Garset-Zamani M; Bruni L; Batis N; Brakenhoff RH; Leemans CR; Baatenburg de Jong RJ; Klussmann JP; Wuerdemann N; Wagner S; Dalianis T; Marklund L; Mirghani H; Schache A; James JA; Huang SH; O'Sullivan B; Nankivell P; Broglie MA; Hoffmann M; Quabius ES; Alemany L;
Lancet Oncol; 2023 Mar; 24(3):239-251. PubMed ID: 36796393
[TBL] [Abstract] [Full Text] [Related]
3. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.
Guven DC; Erul E; Yilmaz F; Yasar S; Yildirim HC; Ercan F; Kaygusuz Y; Cayiroz K; Ucdal MT; Yesil F; Yazici G; Cengiz M; Gullu I; Aksoy S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2471-2478. PubMed ID: 36565325
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis.
Zhang D; Liu J; Zheng M; Meng C; Liao J
World J Surg Oncol; 2022 Oct; 20(1):351. PubMed ID: 36309698
[TBL] [Abstract] [Full Text] [Related]
5. Coexisting Papillary and Anaplastic Thyroid cancer: Elucidating the Spectrum of Aggressive Behavior.
Greenberg JA; Moore MD; Thiesmeyer JW; Egan CE; Lee YJ; Christos P; Zarnegar R; Beninato T; Fahey Iii TJ; Finnerty BM
Ann Surg Oncol; 2023 Jan; 30(1):137-145. PubMed ID: 36224511
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics and prognostic nomogram for patients with insular thyroid carcinoma: a population-based analysis.
Yin L; Hou S; Hou LL; Pu CC
Endocrine; 2023 Feb; 79(2):331-341. PubMed ID: 36207552
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of prognostic nomograms in patients with ascending type of nasopharyngeal carcinoma: Retrospective study based on SEER database.
Chen KH; Jiang YT; Zhao R; Sun YC; Zhu XD
Head Neck; 2022 Dec; 44(12):2649-2659. PubMed ID: 36054033
[TBL] [Abstract] [Full Text] [Related]
8. The association between body mass index and efficacy of pembrolizumab as second-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Zhang X; Rui M; Lin C; Li Z; Wei D; Han R; Ju H; Ren G
Cancer Med; 2023 Feb; 12(3):2702-2712. PubMed ID: 35975731
[TBL] [Abstract] [Full Text] [Related]
9. Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer.
Dai J; Reyimu A; Sun A; Duoji Z; Zhou W; Liang S; Hu S; Dai W; Xu X
Sci Rep; 2022 May; 12(1):8008. PubMed ID: 35568702
[TBL] [Abstract] [Full Text] [Related]
10. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic cancer: A Population-Based Analysis.
Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic impact of perineural invasion in oral cancer: a systematic review.
Quintana DMVO; Dedivitis RA; Kowalski LP
Acta Otorhinolaryngol Ital; 2022 Feb; 42(1):17-25. PubMed ID: 35292785
[TBL] [Abstract] [Full Text] [Related]
12. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid cancer Patients: A Retrospective Study in Southwest China.
Liu Q; Yin M; Li G
Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
[TBL] [Abstract] [Full Text] [Related]
13. A Nutrition and Inflammation-Related Nomogram to Predict Overall Survival in Surgically Resected Esophageal Squamous Cell Carcinoma (ESCC) Patients.
Li J; Mei X; Sun D; Guo M; Xie M; Chen X
Nutr Cancer; 2022; 74(5):1625-1635. PubMed ID: 34369223
[TBL] [Abstract] [Full Text] [Related]
14. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National cancer Center in China.
Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive Analysis of mRNA Expression Profiles in head and neck cancer by Using Robust Rank Aggregation and Weighted Gene Coexpression Network Analysis.
Cao Z; Ao Y; Guo Y; Zhou S
Biomed Res Int; 2020; 2020():4908427. PubMed ID: 33376725
[TBL] [Abstract] [Full Text] [Related]
16. [Positive lymph node ratio ≥0.16 is an independent risk factor affecting the prognosis of patients with esophageal cancer].
Yao W; Lu N; Cui M; Wang J; Du Z; Zhang M
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):837-842. PubMed ID: 32895212
[TBL] [Abstract] [Full Text] [Related]
17. Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The cancer Genome Atlas (TCGA) Database.
Zhang Y; Jin T; Shen H; Yan J; Guan M; Jin X
Med Sci Monit; 2019 Dec; 25():9752-9769. PubMed ID: 31856144
[TBL] [Abstract] [Full Text] [Related]
18. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
Yan B; Hou Y; Chen D; He J; Jiang Y
Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
[TBL] [Abstract] [Full Text] [Related]
19. Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis.
Yao W; Meng Y; Lu M; Fan W; Huang J; Li J; Zhu Z
Cancer Commun (Lond); 2018 Apr; 38(1):14. PubMed ID: 29764483
[TBL] [Abstract] [Full Text] [Related]
20. The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal cancer.
Kano K; Aoyama T; Yoshikawa T; Maezawa Y; Nakajima T; Hayashi T; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Cho H; Ogata T
Ann Surg Oncol; 2018 Jul; 25(7):2034-2043. PubMed ID: 29748890
[TBL] [Abstract] [Full Text] [Related]
[Next]
